
HTG Molecular Diagnostics HTGM
Annual report 2022
added 03-30-2023
HTG Molecular Diagnostics Cash Conversion Cycle 2011-2026 | HTGM
Annual Cash Conversion Cycle HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 104 | 96.9 | 80.9 | 44 | 46.1 | 64.8 | 164 | 226 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 226 | 44 | 103 |
Quarterly Cash Conversion Cycle HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 205 | 131 | 165 | - | 145 | 100 | 113 | - | 95.5 | 87.3 | 86.2 | - | 41.2 | 35.5 | 95.6 | - | 57.2 | 59 | 52.4 | - | 50.3 | 237 | 239 | - | 198 | 140 | 231 | - | 231 | 244 | 180 | - | 174 | 328 | 96.6 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 328 | 35.5 | 141 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
111 | $ 120.75 | 1.47 % | $ 36.7 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.94 | 3.71 % | $ 95.4 K | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 22.99 | -2.36 % | $ 241 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 28.42 | 3.08 % | $ 789 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 179.43 | 2.05 % | $ 8.89 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 14.13 | 2.47 % | $ 427 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
41.7 | $ 15.23 | -1.74 % | $ 1.97 B | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
IDEXX Laboratories
IDXX
|
103 | $ 644.54 | 1.42 % | $ 51.8 B | ||
|
Illumina
ILMN
|
142 | $ 130.66 | 0.85 % | $ 20.8 B | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.15 | 2.23 % | $ 1.46 M | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 208.68 | 0.16 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
77.5 | $ 204.89 | 0.41 % | $ 146 B | ||
|
Organovo Holdings
ONVO
|
-82.8 K | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | $ 103.52 | 0.15 % | $ 19.5 B | ||
|
Bioventus
BVS
|
208 | $ 8.58 | -1.83 % | $ 538 M | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 9.4 | -8.74 % | $ 267 M | ||
|
DexCom
DXCM
|
134 | $ 73.32 | 0.33 % | $ 28.6 B | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
45.3 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-3.19 | $ 26.81 | 7.33 % | $ 34.8 M | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 110.08 | 1.27 % | $ 9.08 B | ||
|
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 19.31 | 2.71 % | $ 1.03 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 281.98 | -0.38 % | $ 23.5 B | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 77.77 | -1.36 % | $ 5.25 B | ||
|
Guardant Health
GH
|
79.6 | $ 94.48 | 1.26 % | $ 11.8 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 176.07 | 1.19 % | $ 30.3 B | ||
|
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 303.14 | -0.98 % | $ 26.9 B |